Today: 8 February 2026
Subscribe
Browse Category

NYSE:STUB News 17 December 2025 - 22 January 2026

StubHub hit with IPO disclosure lawsuit deadline as STUB stock swings again

StubHub hit with IPO disclosure lawsuit deadline as STUB stock swings again

Hagens Berman urged StubHub investors to seek lead-plaintiff status in a securities class action before Jan. 23, citing concerns over vendor payment disclosures in the IPO. StubHub’s free cash flow turned negative $4.6 million last quarter, down from a $10.6 million gain a year earlier. Shares have swung sharply since the September IPO, dropping as low as $10.31 before rebounding to $15.28 Thursday. The original lawsuit was filed Nov. 24 in Manhattan federal court.
15 January 2026
··
StubHub (STUB) Stock News Today (17.12.2025): Partnerships Lift Shares as 13F Buying and Lawsuit Headlines Shape the Outlook

StubHub (STUB) Stock News Today (17.12.2025): Partnerships Lift Shares as 13F Buying and Lawsuit Headlines Shape the Outlook

NEW YORK — December 17, 2025 — StubHub Holdings, Inc. (NYSE: STUB) is back in the spotlight on Wednesday as investors weigh a busy mix of catalysts: an expansion of “Direct Issuance” partnerships that adds more primary-ticket inventory to StubHub’s ecosystem, a newly surfaced institutional position disclosed in a recent 13F filing, and a fresh wave of shareholder-law-firm announcements tied to ongoing securities litigation around the company’s post-IPO disclosures. At the center of today’s conversation is a simple question for markets: Is StubHub’s post-IPO dip a bargain entry into a scaled global ticket marketplace — or a value trap facing
17 December 2025

Stock Market Today

Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead

Thermo Fisher stock holds near $543 after Thursday slide as traders size up layoffs notice, data week ahead

8 February 2026
cNew York, Feb 7, 2026, 17:29 EST — Market closed. Thermo Fisher Scientific (TMO.N) shares ended Friday, Feb. 6, at $542.83, steady on the day after a roughly 4% drop in the prior session. With U.S. markets shut on Saturday, traders head into Monday looking for signs the selloff has run its course. (Thermo Fisher Scientific) The stock has been jumpy because the company sits at the intersection of two messy lines: research spending that can disappear fast, and drugmakers’ demand for tools and services that tends to hold up. That split matters now because the next leg, up or
Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop